AU5006499A - Compositions and methods for the treatment or prevention of pulmonary infections - Google Patents
Compositions and methods for the treatment or prevention of pulmonary infectionsInfo
- Publication number
- AU5006499A AU5006499A AU50064/99A AU5006499A AU5006499A AU 5006499 A AU5006499 A AU 5006499A AU 50064/99 A AU50064/99 A AU 50064/99A AU 5006499 A AU5006499 A AU 5006499A AU 5006499 A AU5006499 A AU 5006499A
- Authority
- AU
- Australia
- Prior art keywords
- prevention
- compositions
- treatment
- methods
- pulmonary infections
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12144798A | 1998-07-23 | 1998-07-23 | |
US09121447 | 1998-07-23 | ||
PCT/US1999/016739 WO2000004915A1 (en) | 1998-07-23 | 1999-07-23 | Compositions and methods for the treatment or prevention of pulmonary infections |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5006499A true AU5006499A (en) | 2000-02-14 |
Family
ID=22396796
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU50064/99A Abandoned AU5006499A (en) | 1998-07-23 | 1999-07-23 | Compositions and methods for the treatment or prevention of pulmonary infections |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU5006499A (en) |
WO (1) | WO2000004915A1 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX352760B (en) | 2011-09-09 | 2017-12-07 | Merck Sharp & Dohme Corp Star | Methods for treating intrapulmonary infections. |
US8809314B1 (en) | 2012-09-07 | 2014-08-19 | Cubist Pharmacueticals, Inc. | Cephalosporin compound |
US8476425B1 (en) | 2012-09-27 | 2013-07-02 | Cubist Pharmaceuticals, Inc. | Tazobactam arginine compositions |
US20140275000A1 (en) | 2013-03-15 | 2014-09-18 | Cubist Pharmaceuticals, Inc. | Ceftolozane pharmaceutical compositions |
MX2020004205A (en) | 2013-03-15 | 2021-11-16 | Merck Sharp & Dohme Llc | Ceftolozane antibiotic compositions. |
US9872906B2 (en) | 2013-03-15 | 2018-01-23 | Merck Sharp & Dohme Corp. | Ceftolozane antibiotic compositions |
WO2015035376A2 (en) | 2013-09-09 | 2015-03-12 | Calixa Therapeutics, Inc. | Treating infections with ceftolozane/tazobactam in subjects having impaired renal function |
US20150094293A1 (en) | 2013-09-27 | 2015-04-02 | Calixa Therapeutics, Inc. | Solid forms of ceftolozane |
MX2017016251A (en) * | 2015-07-02 | 2018-04-20 | Dana Farber Cancer Inst Inc | Stabilized anti-microbial peptides. |
CN109069578A (en) | 2016-02-29 | 2018-12-21 | 达纳-法伯癌症研究所股份有限公司 | For treating the intracellular targeted antimicrobial peptides of the stitching of infection |
CA3060561A1 (en) * | 2017-04-19 | 2018-10-25 | The Regents Of The University Of Colorado, A Body Corporate | Antimicrobial peptides and methods of treating gram-negative pathogens: polar and non-polar face analogs |
US11325955B2 (en) | 2017-07-19 | 2022-05-10 | Dana-Farber Cancer Institute, Inc. | Stabilized anti-microbial peptides for the treatment of antibiotic-resistant bacterial infections |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5994306A (en) * | 1995-11-22 | 1999-11-30 | Intrabiotics Pharmaceuticals, Inc. | Fine-tuned protegrins |
-
1999
- 1999-07-23 AU AU50064/99A patent/AU5006499A/en not_active Abandoned
- 1999-07-23 WO PCT/US1999/016739 patent/WO2000004915A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2000004915A1 (en) | 2000-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4205100A (en) | Methods and compositions for the treatment of pancreatitis | |
HK1040944A1 (en) | Methods and compositions for the prevention and treatment of anemia | |
EP1143956A3 (en) | Compositions and methods for the treatment of anorectal disorders | |
AU2212299A (en) | Compositions and methods for the treatment of tumor | |
AU2951299A (en) | Disinfecting compositions and processes for disinfecting surfaces | |
AUPQ127399A0 (en) | Compositions and methods for treating or preventing osteoporosis | |
AU2001239052A1 (en) | Compositions for prevention and treatment of dementia | |
EP1076547A4 (en) | Derivatives of arabinogalactan and compositions including the same | |
AU2001245977A1 (en) | Method and composition for preventing or reducing the symptoms of menopause | |
HUP0104688A3 (en) | Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer | |
AU2002356868A1 (en) | Methods for the prevention or treatment of bacterial and fungal infections | |
AU4061597A (en) | Treatment of the common cold or allergic rhinitis | |
AU1509999A (en) | Herbal drug composition for the prevention and treatment of dementia | |
AU2469599A (en) | Methods for the prevention and treatment of fibrosis and sclerosis | |
AU5006499A (en) | Compositions and methods for the treatment or prevention of pulmonary infections | |
AU1556497A (en) | Agents for the treatment and prevention of aids | |
AU3065999A (en) | Compositions and methods for treatment of asthma | |
WO2001093878A8 (en) | Bismuth compounds for the treatment and prevention of mucositis | |
AU4228000A (en) | Methods and compositions for the treatment and prevention of lung disease | |
AU2001264522A1 (en) | Methods and compositions for the prevention of myopia | |
AU2001255730A1 (en) | Methods and compositions for the treatment of cardiac indications | |
AU4225500A (en) | Methods and compositions for the treatment and prevention of lung disease | |
AU3103097A (en) | Compositions and methods for the treatment of chronic infections | |
AU2002228500A1 (en) | Methods and compositions for reducing or preventing onset of milk fever | |
AU2000265105A1 (en) | Methods and compositions for the prevention and treatment of syndrome x |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |